Type 2 Diabetes Clinical Trials in Washington D.C., District of Columbia

4 studies are recruiting for type 2 diabetes in Washington D.C., District of Columbia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

    Background: Type 2 diabetes is a disease that affects blood sugar levels. Complications can include heart and blood vessel (vascular) diseases. Rates of type 2 diabetes have tripled in children and young adults over the last 40 years. Vascular diseases are also increasing in young people. Objective…

    Stage
    Not phased
    Ages
    12 to 25
    Site
    Children's National Hospital (CNH), Washington D.C., District of Columbia
    Locations
    2 in total
    Run by
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    See if you can join NCT06730113 on ClinicalTrials.gov

  2. Plant-Based Online Weight Loss Through Education and Resources Program and Study

    This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Participants will meet with a physician and a registered dietitian once a week to learn about a plant-based diet a…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Physicians Committee for Responsible Medicine, Washington D.C., District of Columbia
    Run by
    Physicians Committee for Responsible Medicine

    See if you can join NCT07095543 on ClinicalTrials.gov

  3. A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

    The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.

    Stage
    Phase 3
    Ages
    10 to 17
    Site
    Emerson Clinical Research Institute, Washington D.C., District of Columbia
    Locations
    51 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06739122 on ClinicalTrials.gov

  4. Diabetes Reversal Online Program and Study (DROP Study)

    This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Data will also be analyzed to see if participation in the program results in reductions glycated hemoglobin levels…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Physician Committee for Responsible Medicine, Washington D.C., District of Columbia
    Run by
    Physicians Committee for Responsible Medicine

    See if you can join NCT05572502 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.